HEADER TRANSFERASE/INHIBITOR 03-JAN-23 8FP3 TITLE PKCETA KINASE DOMAIN IN COMPLEX WITH COMPOUND 11 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN KINASE C ETA TYPE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 333-683; COMPND 5 SYNONYM: PKC-L,NPKC-ETA; COMPND 6 EC: 2.7.11.13; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PRKCH, PKCL, PRKCL; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: SF21 KEYWDS HPK1, STRUCTURE BASED DRUG DESIGN, CANCER, KINASE, TRANSFERASE, KEYWDS 2 TRANSFERASE-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR E.JOHNSON REVDAT 2 26-APR-23 8FP3 1 JRNL REVDAT 1 05-APR-23 8FP3 0 JRNL AUTH R.A.GALLEGO,L.BERNIER,H.CHEN,S.CHO-SCHULTZ,L.CHUNG, JRNL AUTH 2 M.COLLINS,M.DEL BEL,J.ELLERAAS,C.COSTA JONES,C.N.CRONIN, JRNL AUTH 3 M.EDWARDS,X.FANG,T.FISHER,M.HE,J.HOFFMAN,R.HUO,M.JALAIE, JRNL AUTH 4 E.JOHNSON,T.W.JOHNSON,R.S.KANIA,M.KRAUS,J.LAFONTAINE,P.LE, JRNL AUTH 5 T.LIU,M.MAESTRE,J.MATTHEWS,M.MCTIGUE,N.MILLER,Q.MU,X.QIN, JRNL AUTH 6 S.REN,P.RICHARDSON,A.ROHNER,N.SACH,L.SHAO,G.SMITH,R.SU, JRNL AUTH 7 B.SUN,S.TIMOFEEVSKI,P.TRAN,S.WANG,W.WANG,R.ZHOU,J.ZHU, JRNL AUTH 8 S.K.NAIR JRNL TITL DESIGN AND SYNTHESIS OF FUNCTIONALLY ACTIVE 5-AMINO-6-ARYL JRNL TITL 2 PYRROLOPYRIMIDINE INHIBITORS OF HEMATOPOIETIC PROGENITOR JRNL TITL 3 KINASE 1. JRNL REF J.MED.CHEM. V. 66 4888 2023 JRNL REFN ISSN 0022-2623 JRNL PMID 36940470 JRNL DOI 10.1021/ACS.JMEDCHEM.2C02038 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 17907 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : FREE R-VALUE REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.198 REMARK 3 FREE R VALUE : 0.256 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : NULL REMARK 3 BIN R VALUE (WORKING + TEST SET) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2691 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 26 REMARK 3 SOLVENT ATOMS : 172 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : NULL REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : NULL REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : NULL ; NULL ; NULL REMARK 3 BOND ANGLES : NULL ; NULL ; NULL REMARK 3 TORSION ANGLES : NULL ; NULL ; NULL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : NULL ; NULL ; NULL REMARK 3 ISOTROPIC THERMAL FACTORS : NULL ; NULL ; NULL REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : NULL ; NULL ; NULL REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : NULL ; NULL ; NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : NULL REMARK 3 OTHER TORSION ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8FP3 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 13-JAN-23. REMARK 100 THE DEPOSITION ID IS D_1000269755. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-APR-17 REMARK 200 TEMPERATURE (KELVIN) : 87.15 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AUTOPROC REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 18820 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.290 REMARK 200 RESOLUTION RANGE LOW (A) : 77.740 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.2 REMARK 200 DATA REDUNDANCY : 6.400 REMARK 200 R MERGE (I) : 0.10300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.29 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.33 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.2 REMARK 200 DATA REDUNDANCY IN SHELL : 6.80 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.76 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.40 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: WELL INGREDIENTS: PRECIPITANT: 21.0 REMARK 280 %W/V (10.5 UL OF STOCK 50.0 %W/V) PEG 3350 SALT: 0.7 M (2.1875 REMARK 280 UL OF STOCK 8.0 M) LITHIUM NITRATE BUFFER: 0.1 M (2.5 UL OF REMARK 280 STOCK 1.0 M) MES (PH 6.00) ORGANIC (NON-VOLATILE): 7.0 % W/V REMARK 280 (2.1875 UL OF STOCK 80.0 % W/V) GLYCEROL [PROTIEN] = 12 MG/ML, REMARK 280 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 286.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 26.11950 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 47.77100 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 38.86800 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 47.77100 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 26.11950 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 38.86800 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 331 REMARK 465 SER A 332 REMARK 465 LYS A 333 REMARK 465 GLU A 334 REMARK 465 SER A 335 REMARK 465 SER A 336 REMARK 465 LYS A 337 REMARK 465 GLU A 338 REMARK 465 GLY A 339 REMARK 465 ASN A 340 REMARK 465 GLY A 341 REMARK 465 ILE A 342 REMARK 465 GLY A 343 REMARK 465 VAL A 344 REMARK 465 ASN A 345 REMARK 465 SER A 346 REMARK 465 SER A 347 REMARK 465 ASN A 348 REMARK 465 GLU A 680 REMARK 465 LEU A 681 REMARK 465 GLN A 682 REMARK 465 PRO A 683 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 ARG A 349 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 449 -47.03 75.02 REMARK 500 ARG A 478 -3.18 67.06 REMARK 500 ASP A 497 93.86 68.91 REMARK 500 MET A 589 43.02 -99.36 REMARK 500 PRO A 653 56.49 -96.37 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A9272 DISTANCE = 11.14 ANGSTROMS REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 8FH4 RELATED DB: PDB REMARK 900 HPK1 KINASE COMPLEXED WITH COMPOUND 2 REMARK 900 RELATED ID: 8FJZ RELATED DB: PDB REMARK 900 HPK1 KINASE COMPLEXED WITH COMPOUND 11 REMARK 900 RELATED ID: 8FKO RELATED DB: PDB REMARK 900 HPK1 KINASE COMPLEXED WITH COMPOUND 19 REMARK 900 RELATED ID: 8FP1 RELATED DB: PDB REMARK 900 SAME PROTEIN COMPLEXED WITH COMPOUND 2 DBREF 8FP3 A 333 683 UNP P24723 KPCL_HUMAN 333 683 SEQADV 8FP3 GLY A 331 UNP P24723 EXPRESSION TAG SEQADV 8FP3 SER A 332 UNP P24723 EXPRESSION TAG SEQADV 8FP3 GLU A 675 UNP P24723 SER 675 ENGINEERED MUTATION SEQRES 1 A 353 GLY SER LYS GLU SER SER LYS GLU GLY ASN GLY ILE GLY SEQRES 2 A 353 VAL ASN SER SER ASN ARG LEU GLY ILE ASP ASN PHE GLU SEQRES 3 A 353 PHE ILE ARG VAL LEU GLY LYS GLY SER PHE GLY LYS VAL SEQRES 4 A 353 MET LEU ALA ARG VAL LYS GLU THR GLY ASP LEU TYR ALA SEQRES 5 A 353 VAL LYS VAL LEU LYS LYS ASP VAL ILE LEU GLN ASP ASP SEQRES 6 A 353 ASP VAL GLU CYS THR MET THR GLU LYS ARG ILE LEU SER SEQRES 7 A 353 LEU ALA ARG ASN HIS PRO PHE LEU THR GLN LEU PHE CYS SEQRES 8 A 353 CYS PHE GLN THR PRO ASP ARG LEU PHE PHE VAL MET GLU SEQRES 9 A 353 PHE VAL ASN GLY GLY ASP LEU MET PHE HIS ILE GLN LYS SEQRES 10 A 353 SER ARG ARG PHE ASP GLU ALA ARG ALA ARG PHE TYR ALA SEQRES 11 A 353 ALA GLU ILE ILE SER ALA LEU MET PHE LEU HIS ASP LYS SEQRES 12 A 353 GLY ILE ILE TYR ARG ASP LEU LYS LEU ASP ASN VAL LEU SEQRES 13 A 353 LEU ASP HIS GLU GLY HIS CYS LYS LEU ALA ASP PHE GLY SEQRES 14 A 353 MET CYS LYS GLU GLY ILE CYS ASN GLY VAL THR THR ALA SEQRES 15 A 353 TPO PHE CYS GLY THR PRO ASP TYR ILE ALA PRO GLU ILE SEQRES 16 A 353 LEU GLN GLU MET LEU TYR GLY PRO ALA VAL ASP TRP TRP SEQRES 17 A 353 ALA MET GLY VAL LEU LEU TYR GLU MET LEU CYS GLY HIS SEQRES 18 A 353 ALA PRO PHE GLU ALA GLU ASN GLU ASP ASP LEU PHE GLU SEQRES 19 A 353 ALA ILE LEU ASN ASP GLU VAL VAL TYR PRO THR TRP LEU SEQRES 20 A 353 HIS GLU ASP ALA THR GLY ILE LEU LYS SER PHE MET THR SEQRES 21 A 353 LYS ASN PRO THR MET ARG LEU GLY SER LEU THR GLN GLY SEQRES 22 A 353 GLY GLU HIS ALA ILE LEU ARG HIS PRO PHE PHE LYS GLU SEQRES 23 A 353 ILE ASP TRP ALA GLN LEU ASN HIS ARG GLN ILE GLU PRO SEQRES 24 A 353 PRO PHE ARG PRO ARG ILE LYS SER ARG GLU ASP VAL SER SEQRES 25 A 353 ASN PHE ASP PRO ASP PHE ILE LYS GLU GLU PRO VAL LEU SEQRES 26 A 353 TPO PRO ILE ASP GLU GLY HIS LEU PRO MET ILE ASN GLN SEQRES 27 A 353 ASP GLU PHE ARG ASN PHE GLU TYR VAL SER PRO GLU LEU SEQRES 28 A 353 GLN PRO MODRES 8FP3 TPO A 513 THR MODIFIED RESIDUE MODRES 8FP3 TPO A 656 THR MODIFIED RESIDUE HET TPO A 513 11 HET TPO A 656 11 HET Y3I A9000 26 HETNAM TPO PHOSPHOTHREONINE HETNAM Y3I (3P)-3-{4-[(3R,5S)-3-AMINO-5-METHYLPIPERIDIN-1-YL]-6- HETNAM 2 Y3I CHLORO-7H-PYRROLO[2,3-D]PYRIMIDIN-5-YL}BENZONITRILE HETSYN TPO PHOSPHONOTHREONINE FORMUL 1 TPO 2(C4 H10 N O6 P) FORMUL 2 Y3I C19 H19 CL N6 FORMUL 3 HOH *172(H2 O) HELIX 1 AA1 GLY A 351 ASP A 353 5 3 HELIX 2 AA2 LYS A 388 ASP A 394 1 7 HELIX 3 AA3 ASP A 396 ALA A 410 1 15 HELIX 4 AA4 ASP A 440 ARG A 449 1 10 HELIX 5 AA5 ASP A 452 LYS A 473 1 22 HELIX 6 AA6 LYS A 481 ASP A 483 5 3 HELIX 7 AA7 THR A 517 ILE A 521 5 5 HELIX 8 AA8 ALA A 522 GLN A 527 1 6 HELIX 9 AA9 PRO A 533 GLY A 550 1 18 HELIX 10 AB1 ASN A 558 ASP A 569 1 12 HELIX 11 AB2 HIS A 578 MET A 589 1 12 HELIX 12 AB3 ASN A 592 ARG A 596 5 5 HELIX 13 AB4 SER A 599 GLY A 604 5 6 HELIX 14 AB5 GLU A 605 ARG A 610 1 6 HELIX 15 AB6 HIS A 611 LYS A 615 5 5 HELIX 16 AB7 ASP A 618 HIS A 624 1 7 HELIX 17 AB8 ASP A 645 LYS A 650 1 6 HELIX 18 AB9 HIS A 662 ILE A 666 5 5 HELIX 19 AC1 ASN A 667 ARG A 672 5 6 SHEET 1 AA1 6 PHE A 355 GLY A 364 0 SHEET 2 AA1 6 GLY A 367 VAL A 374 -1 O LEU A 371 N ARG A 359 SHEET 3 AA1 6 LEU A 380 LYS A 387 -1 O VAL A 385 N LYS A 368 SHEET 4 AA1 6 ARG A 428 MET A 433 -1 O MET A 433 N ALA A 382 SHEET 5 AA1 6 LEU A 419 GLN A 424 -1 N CYS A 421 O VAL A 432 SHEET 6 AA1 6 TYR A 676 VAL A 677 -1 O TYR A 676 N CYS A 422 SHEET 1 AA2 2 VAL A 485 LEU A 487 0 SHEET 2 AA2 2 CYS A 493 LEU A 495 -1 O LYS A 494 N LEU A 486 LINK C ALA A 512 N TPO A 513 1555 1555 1.33 LINK C TPO A 513 N PHE A 514 1555 1555 1.33 LINK C LEU A 655 N TPO A 656 1555 1555 1.33 LINK C TPO A 656 N PRO A 657 1555 1555 1.33 CRYST1 52.239 77.736 95.542 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019143 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012864 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010467 0.00000